No Data
No Data
No Data
No Data
No Data
Express News | Corcept Completes Enrollment In Phase 2 DAZALS Trial In Patients With Amyotrophic Lateral Sclerosis
Moomoo 24/7Apr 15 08:09 ET
Express News | Corcept Completes Enrollment in Phase 2 Dazals Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
Moomoo 24/7Apr 15 08:00 ET
Corcept (CORT) Completes Enrollment in Ovarian Cancer Study
Yahoo FinanceApr 9 11:09 ET
Corcept Therapeutics(CORT.US) Officer Sells US$141.52K in Common Stock
$Corcept Therapeutics(CORT.US)$ Officer Lyon Joseph Douglas sold 5,443 shares of common stock on Apr 4, 2024 at an average price of $26.0011 for a total value of $141.52K.Source: Announcement What is
moomoo NewsApr 8 18:57 ET
Express News | Corcept Completes Enrollment In Pivotal Phase 3 Rosella Trial Of Relacorilant In Patients With Platinum-Resistant Ovarian Cancer
Moomoo 24/7Apr 8 08:05 ET
Form 144 | Corcept Therapeutics(CORT.US) Officer Proposes to Sell 256.5K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 4, $Corcept Therapeutics(CORT.US)$ Officer Lyon Joseph Douglas intends to sell 10,000 shares of its common stock on Apr 4, with a total market value of approximately $256.5
moomoo NewsApr 4 12:46 ET
No Data
No Data